|
Loxapine SuccinateDrug - Loxapine Succinate The trade name of the product as shown on the labeling.
Dosage -
CAPSULE; ORAL
Active Ingredient(s) -
Loxapine Succinate
Strength -
EQ 50MG BASE
Applicant -
WATSON LABS
New Drug Application (NDA) Number -
072062
Product Number -
001
Therapeutic Equivalence (TE) Code -
AB
Approval Date -
Jun 15, 1988
Reference Listed Drug (RLD) -
No
Type -
RX
Applicant Full Name -
Watson Laboratories Inc
Loxapine Succinate
Loxapine Eq 50mg Base Capsule; Oral
Loxapine Eq 5mg Base Capsule; Oral Loxapine Succinate Eq 10mg Base Capsule; Oral Loxapine Succinate Eq 25mg Base Capsule; Oral Loxapine Succinate Eq 50mg Base Capsule; Oral Loxapine Succinate Eq 5mg Base Capsule; Oral Loxapine Succinate Eq 10mg Base Capsule; Oral Loxapine Succinate Eq 25mg Base Capsule; Oral Loxapine Succinate Eq 50mg Base Capsule; Oral Loxapine Eq 25mg Base Capsule; Oral NewDrugInformation |